Cargando…

Herbal-drug interaction induced rhabdomyolysis in a liposarcoma patient receiving trabectedin

BACKGROUND: Rhabdomyolysis is an uncommon side effect of trabectedin which is used for the second line therapy of metastatic sarcoma after anthracycline and ifosfamide failure. This side effect may be due to pharmacokinetic interactions caused by shared mechanisms of metabolism involving the cytochr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Strippoli, Sabino, Lorusso, Vito, Albano, Anna, Guida, Michele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3737021/ https://www.ncbi.nlm.nih.gov/pubmed/23899130 http://dx.doi.org/10.1186/1472-6882-13-199

Ejemplares similares

Safely combining trabectedin with radiotherapy to treat myxoid liposarcoma
por: Chen, Mark, et al.
Publicado: (2019)

Severe Rhabdomyolysis during Treatment with Trabectedin in Combination with a Herbal Drug in a Patient with Metastatic Synovial Sarcoma: A Case Report
por: Damato, Angela, et al.
Publicado: (2017)

Tumor Calcification: A New Response Pattern of Myxoid Liposarcoma to Trabectedin
por: Turpin, Anthony, et al.
Publicado: (2014)

Eribulin Provides a Remarkable Effect in Trabectedin-Resistant Myxoid Liposarcoma
por: Tamiya, Hironari, et al.
Publicado: (2020)

Trabectedin as second-line treatment in metastatic myxoid liposarcoma: a case report
por: Pedrinaci, Irene Zarcos, et al.
Publicado: (2012)

Case Report of Suspected Rhabdomyolysis during Treatment with Trabectedin in a Patient with Metastatic Leiomyosarcoma
por: Lamm, W., et al.
Publicado: (2010)

Complete remission of a reccurrent mesenteric liposarcoma with rare histological features following the administration of trabectedin
por: TSOUKALAS, N., et al.
Publicado: (2014)

Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin
por: Bello, Ezia, et al.
Publicado: (2019)

Long-term disease control by trabectedin in a patient with dedifferentiated liposarcoma: A case report
por: Matsuda, Shogo, et al.
Publicado: (2020)

Impact of Pathological Stratification on the Clinical Outcomes of Advanced Well-Differentiated/Dedifferentiated Liposarcoma Treated with Trabectedin
por: Fabbroni, Chiara, et al.
Publicado: (2021)

Cervical cancer benefits from trabectedin combination with the β-blocker propranolol: in vitro and ex vivo evaluations in patient-derived organoids
por: Di Fonte, Roberta, et al.
Publicado: (2023)

A comprehensive safety analysis confirms rhabdomyolysis as an uncommon adverse reaction in patients treated with trabectedin
por: Grosso, Federica, et al.
Publicado: (2012)

Correction: Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin
por: Bello, Ezia, et al.
Publicado: (2020)

A Systems Biology Approach to Characterize the Regulatory Networks Leading to Trabectedin Resistance in an In Vitro Model of Myxoid Liposarcoma
por: Uboldi, Sarah, et al.
Publicado: (2012)

Management Strategies in Advanced Uterine Leiomyosarcoma: Focus on Trabectedin
por: Amant, Frédéric, et al.
Publicado: (2015)

The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale)
por: Guida, Michele, et al.
Publicado: (2018)

Drug induced rhabdomyolysis
por: Hohenegger, Martin
Publicado: (2012)

Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model
por: Kiyuna, Tasuku, et al.
Publicado: (2018)

Diclofenac- and Pantoprazole-Induced Rhabdomyolysis: A Potential Drug Interaction
por: Ertekin, Yusuf Haydar, et al.
Publicado: (2015)

Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma
por: Cucè, Maria, et al.
Publicado: (2019)

Trabectedin and Plitidepsin: Drugs from the Sea that Strike the Tumor Microenvironment
por: Galmarini, Carlos M., et al.
Publicado: (2014)

Trabectedin in Soft Tissue Sarcomas
por: Petek, Bradley J., et al.
Publicado: (2015)

Trabectedin for soft tissue sarcoma
Publicado: (2021)

Rhabdomyolysis from spinning exercise and ephedra-contained herbal medicine
por: Ryu, Hoyoung, et al.
Publicado: (2016)

Overall survival and histology‐specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma
por: Patel, Shreyaskumar, et al.
Publicado: (2019)

Statin-induced rhabdomyolysis: a complication of a commonly overlooked drug interaction
por: Ezad, Saad, et al.
Publicado: (2018)

Trabectedin: A drug from the sea that strikes tumor-associated macrophages
por: Allavena, Paola, et al.
Publicado: (2013)

Trabectedin, a drug acting on both cancer cells and the tumour microenvironment
por: D'Incalci, M, et al.
Publicado: (2014)

Increased sensitivity to platinum drugs of cancer cells with acquired resistance to trabectedin
por: Colmegna, B, et al.
Publicado: (2015)

Pioglitazone-Induced Acute Rhabdomyolysis
por: Slim, Raoudha, et al.
Publicado: (2009)

Dexmethylphenidate-Induced Rhabdomyolysis by Interaction With Aromatase Inhibitor
por: Huang, Derrick, et al.
Publicado: (2022)

Drug-Induced Rhabdomyolysis with Elevated Cardiac Troponin T
por: Egholm, Gro, et al.
Publicado: (2015)

Non-traumatic and non-drug-induced rhabdomyolysis
por: Kolovou, Genovefa, et al.
Publicado: (2019)

The Role of Trabectedin in Soft Tissue Sarcoma
por: Nakamura, Tomoki, et al.
Publicado: (2022)

Proteomic Profile and In Silico Analysis in Metastatic Melanoma with and without BRAF Mutation
por: Garrisi, Vito Michele, et al.
Publicado: (2014)

Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedin
por: Jones, Robin L., et al.
Publicado: (2019)

Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms
por: Romano, Michela, et al.
Publicado: (2017)

Rhabdomyolysis secondary to drug interaction between atorvastatin, omeprazole, and dexamethasone
por: Elazzazy, Shereen, et al.
Publicado: (2012)

αβ-Double Negative CD4/CD8 (CD56) T cell (DNTs) in metastatic melanoma: basal frequency and behaviour during Ipilimumab treatment. Preliminary evaluations
por: De Tullio, Giacoma, et al.
Publicado: (2015)

Determination of Extravasation Effects of Nal-Iri and Trabectedin and Evaluation of Treatment Options for Trabectedin Extravasation in a Preclinical Animal Model
por: Keritam, Omar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kt6ictctrsb32n6jks3bp5bbne